16^th International Conference on Orthopedics, Arthroplasty and Rheumatology May 22-23, 2023 Madrid, Spain

Dr.Robby is a professor at Foro Italico University of Rome since 2013. He studied atUniversity degree: “Sapienza” School of Medicine, Rome, Italy. Specialization: Orthopaedic Surgery Residency , Clinic for Orthopaedic Surgery and Traumatology, “Tor Vergata” University, Rome, Italy. He is an ordinary member of SIOT (Italian society of Orthopaedic and traumatology ).SECEC-ESSE ( European Society for Surgery of the Shoulder and the Elbow). SICSeG (Italian Society of the Shoulder and Elbow Surgery) SIA (Italian society of arthroscopy).SIGASCOT (Italian Society for surgery of knee, arthroscopy, sport, cartilage and orthopaedic technology.

Trauma surgery and Adult joint reconstruction, Orthopedic trauma, shoulder and knee and Arthroscopy

Dr.Michael Vitek, Specialist in Orthopedics and Orthopedic Surgery since 31/07/1988.Vitek is working from 1992 to the end of 2005 leader of the Orthopedic Department of the private clinic Grinzing. Between 2001 and 2005 deputy medical director and medical director of the private clinic Grinzing. In March 2007 opening of the Center for Foot and Joint Surgery in Vienna Meidling. Since 3/2013 Lecturer and Professor of foot surgery at Universidad Autonoma de Guadalajara, Villahermosa, Tabasco, Mexico. Presently he is working in Center for Foot and Joint Surgery Vienna, Austria

Foot and joint

Dr. Lane is the Associate Director of the Orthopaedic Trauma Service at New York-Presbyterian Hospital. He has published extensively on bone biology, tissue injury and repair, trauma, bone and soft tissue sarcomas, limb preservation, functional amputations, limb regeneration, and metabolic bone diseases (osteoporosis, Paget’s disease, rickets, osteomalacia, fibrous dysplasia). He has served on numerous committees for the AAOS, including the Board of Directors and Chairman of COMSS, the Chairman Oversight Panel on Women’s Health Issues. He was President of the Orthopaedic Research Society, Musculoskeletal Tumor Society, Chairman of NIH Orthopaedic Study Section, OREF grants review board, ABOS Question Writing Task Force. He is a member of the AAOS, AOA, ABJS, ASBMR, ORS, MSTS, and OTA. He has earned NIH career and R01 grants, OREF grants, and foundation awards.

Osteoporosis, Paget’s disease, Rickets, Osteomalacia, Fibrous dysplasia.

Eric Lowenstein is the CEO of Tego Insurance, an Australian-based underwriting agency providing medical indemnity insurance for medical professionals. Eric’s qualifications include a bachelor’s degree in business administration and law from Macquarie University, a master’s degree from UNSW in law and management and an MBA from the AGSM. Prior to founding Tego, Eric’s career spanned both insurance and legal services and he held positions at Aon, Mega Capital, Liberty International Underwriters and Norton Rose Fulbright. Eric is actively involved in a number of community organisations and serves as a board member of the Wolper Hospital. Recognised as an expert in the Australian and international insurance markets, Eric is a regular speaker and chairperson at industry conferences and events. He is known by his clients for his strategic and commercial approach, coupled with his personable nature.

International insurance markets

Nikolaos Christodoulou is Chairman of Orthopedic Surgical Department in Iatriko Psychikou Clinic - Athens Medical Group (Greece). He has studied medicine in the University of Athens having succeeded the Greek National Scholarship IKY. He had courses in internal medicine by “Exchange Program of Students” in Frankfurt University in Germany, the experience of a biostatistics annual program of the University of Athens and a stage in the post of Assisted Researcher in Research Cancer Center “G. Papanikolaou” in Athens. He was specialised in orthopedic surgery in Asclepeion Orthopedic Hospital of Hellenic Red Cross. He has been Consultant Orthopedic Surgeon in Asklepeion Orthopedic Hospital at Athens in1983-1985 and received his PhD from the University of Athens in 1985 concerning the influence of intrinsic factors in the anatomical pattern and location of fractures of the proximal femur. He has been also Consultant Orthopedic Surgeon-Orthopedic Department of Korinthos Hospital, Greece (1985-1989), Chief Clinical Director, Orthopedic Department of Karpenissi Hospital, Greece (1989-2009), Chief Clinical Director, Orthopedic Department of “White Cross” Hospital, Athens, Greece (2009-2011) and from 2011 Chairman Clinical Director of Orthopedic Department of Iatriko Psychikou Clinic - Athens Medical Group. He has published many clinical and research works accompanied by extensive citation concerning mainly Hip Fractures, Hip arthroplasties, High Hip Center technique in Congenital Hip Dislocation cases, Anterolateral Knee instability, Knee osteotomies, Hip, Knee and Foot External fixation, New MIS hip approaches and the ALMIS personal technique using a different surgical table and legs position during femoral exposure.

New ALMIS (Antero -Lateral Minimally Invasive Surgery) hip approach (personal technique); Arthroplasties in OA secondary to Congenital Hip Desease; High Hip Center Technique; Modern Hip and Knee Arthroplasties; Partial medial compartment knee arthroplasty; Patellofemoral arthroplasty; Surgical correction of legs deformities; Correction of spastic deformities; External Fixation of sub-trochanteric fractures and knee osteotomies (personal techniques and external fixators); Surgical correction of foot deformities.

Dr. Burkhard F. Leeb was born in Vienna on August 23rd, 1956. He received his specialization in rheumatology in 1994. He was appointed director of the newly established center for rheumatology, Lower Austria, at Stockerau Hospital in 1999. In collaboration with his co-workers he was able to establish this institution in Austrian rheumatology within a relative short time period. Aside this occupation Dr. Leeb had the honor to serve as president of the Austrian society for rheumatology and rehabilitation between 2008 and 2010, as well as a member and also as co-convenor of several EULAR task-forces, amongst them the ones for osteoarthritis and gout. Up to date Dr. Leeb has published more than 150 articles in peer reviewed journals, and in books, amongst them meta-analyses on chondroitin sulfate, and diacerein, EULAR response criteria for polymyalgia rheumatica, and a respective disease activity score.

His main scientific interests are arthritides, polymyalgia rheumatica, as well as osteoarthritis and above all the problems along with disease activity assessment.

Dr. Jan Willem Cohen Tervaert is basically from The Netherlands. He is a graduate of the Medical School, Groningen, the Netherlands. In 1993, he became Medical specialist with clinics in different locations; specialization: disorders such as systemic auto-immune diseases, vasculitis, foreign body reactions, immune defiencies and unsolved clinical problems. He was appointed as Head of the Immunology Laboratory as well as Medical specialist, Department of Internal Medicine, Reumatology and Gastro-enterology in University Hospital Maastricht, Maastricht in 2000. In 2012, he was appointed as Research Director, Franciscus Gasthuis & Vlietland, Rotterdam. Previously he was working as Professor of Internal Medicine and Immunology, Maastricht University, Maastricht, the Netherlands. Currently he is serving as Professor in University of Alberta, and Director, division of Rheumatology, UA, Edmonton, Canada.

His main scientific interests are Internal Medicine and Immunology.

Piotr Gluszko is Professor of Medicine and Head of the Department of Rheumatology at the National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland. He obtained his medical degree from the Faculty of Medicine, Copernicus Medical Academy, Cracow, Poland in 1975. He received his training in internal medicine at the Jagiellonian University Hospital in Cracow. In 1983-84 and 1990/91 he got training appointment as a research associate at the University of Pennsylvania Medical School, Philadelphia, USA. In 1991 he obtained specialisation in clinical rheumatology in Warsaw at the Institute of Rheumatology. In years 1991- 2010 he was appointed Associate Professor and Head of the Rheumatology Unit at the Jagiellonian University, Medical College in Cracow. Professor Gluszko attained his PhD at Jagiellonian University in 1999. He is involved in basic and clinical research on the inflammatory rheumatic diseases, blood vessel and coagulation disorders, and secondary osteoporosis. Since 1976 Piotr Gluszko has been continuously engaged in patient care and teaching of internal medicine, rheumatic and bone diseases. Professor Gluszko has published over 150 articles and book chapters in the field of internal medicine, rheumatology and osteoporosis.

Field of internal medicine, rheumatology and osteoporosis.

Demosthenes Bouros is a graduate of the Medical School of the Aristotelian University of Thessaloniki and a PhD of the University of Athens. He was a research fellow at the Harvard University in Boston, Visiting Assistant Professor at the Boston University, senior Research Associate at the Royal Brompton Hospital and ERS visiting professor of the Medical University of Vienna. He is currently Professor of Pneumonology at the National and Kapodistrian University of Athens, Greece. He has published >400 articles in national and international peer-review journals, has >15.000 citations, H index 60 (Google Scholar), he wrote >40 chapters in books, is member of the Editorial Board of many medical journals. He was a member of the committee for the development guidelines for idiopathic pulmonary fibrosis and the new classification of idiopathic interstitial pneumonias. He has been elected as foundation member of the Fellows of the European Respiratory Society (FERS).

His main research interests include the pathogenetic mechanisms and treatment of interstitial lung diseases and sarcoidosis and the role of stem cells in chronic lung diseases

Dr. Concepción Marañón got her PhD in Biochemistry in 1998 at the University of Granada (Spain) through the study of the biology and immunogenicity of the protozoan parasite Trypanosoma cruzi. Afterwards she moved to Institut Cochin in Paris working on the role of different immune populations in the physiopathology of HIV infection and the mechanisms of immune protection against the virus. From 2011 she switched to the autoimmunity field, and currently she focus in the functional validation of genes involved in susceptibility to systemic autoimmune diseases, as well as the discovery of relevant biomarkers for their precision diagnosis.

Genomic Medicine, autoimmune diseases and diagnosis